196-210 of 284
Vutrisiran for ATTR-CM: Exploring an RNAi Therapeutic
Spotlight On ATTR-CMVutrisiran for ATTR-CM: Exploring an RNAi Therapeutic
Exercise in Multiple Myeloma: Balancing Benefits and Safety
Project Oncology®Exercise in Multiple Myeloma: Balancing Benefits and Safety
Jens Hillengass, MD, PhD
Rozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids
NeuroFrontiersRozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids
Gil I. Wolfe MD, FAAN
Challenges in DMD: Understanding the Height Factor
NeuroFrontiersChallenges in DMD: Understanding the Height Factor
Newly Diagnosed Multiple Myeloma: The Prognostic Significance of Lymphopenia
Project Oncology®Newly Diagnosed Multiple Myeloma: The Prognostic Significance of Lymphopenia
NKX019: A Potential New Frontier in Generalized Myasthenia Gravis Therapy
NeuroFrontiersNKX019: A Potential New Frontier in Generalized Myasthenia Gravis Therapy
- advertisement
Diagnosing IgAN: The Importance of Early and Accurate Identification
Clinician's RoundtableDiagnosing IgAN: The Importance of Early and Accurate Identification
James Chevalier, MD
Investigating the Incidence of IgA Nephropathy Among Racial and Ethnic Groups
Clinician's RoundtableInvestigating the Incidence of IgA Nephropathy Among Racial and Ethnic Groups
John Sim, MD
Diagnosing Castleman Disease: Key Considerations
Project Oncology®Diagnosing Castleman Disease: Key Considerations
Mateo Bustamante
Improving Diagnosis of Castleman Disease: The Key Role of Stromal Cells
Project Oncology®Improving Diagnosis of Castleman Disease: The Key Role of Stromal Cells
Joshua Brandstadter, MD, PhD, MSc
IgAN Explained: Key Differences from Other Kidney Conditions
Clinician's RoundtableIgAN Explained: Key Differences from Other Kidney Conditions
Mohamed Ibrahim, MB, BCh
Nutritional Strategies for Managing IgA Nephropathy
Clinician's RoundtableNutritional Strategies for Managing IgA Nephropathy
Jennifer Moore, MS, RDN, CSR, LDN
Charles Turck, PharmD, BCPS, BCCCP
- advertisement
Zilucoplan: A Promising Potential Treatment for Myasthenia Gravis
NeuroFrontiersZilucoplan: A Promising Potential Treatment for Myasthenia Gravis
Rare Kidney Disease: A Parent and Caregiver’s Perspective
Clinician's RoundtableRare Kidney Disease: A Parent and Caregiver’s Perspective
Gates B. Colbert, MD
Kelly Helm
Decoding Proteinuria: A Window into Kidney Health in IgAN
Clinician's RoundtableDecoding Proteinuria: A Window into Kidney Health in IgAN
